Workshop - 'First In Human (FIH)' of DIA

START Shanghai chairs a full-day workshop for the 4th DIA China Annual Meeting


The topic of this workshop – First In Human (FIH)

Scientifically and effectively evaluate the new medicine has been emphasized by SFDA again during the ‘National Clinical research Quality Management Conference’ on Dec 8, 2011. To facilitate the development of ‘significant innovative new medicines’ and to provide the services to the establishment of innovative country, it is critical to upgrade the capacity and capability of First-time-in-Human trial in China.

START Shanghai’s CEO, Carol Zhu is one of the co-chairs of this workshop. Several important figures in the field are invited as instructors of this workshop. They are:

Pei Hu, MD, MPH

Professor and Director, Clinical Pharmacology Research Center, Peking Union Medical College Hospital, China

Helen Jiang, MD,PhD

Executive Medical Director, Jiangsu Hengrui Medicine Co., Ltd., China

Chia-Chi Lin, MD, PhD

Director of Phase I Center, Department of Oncology, National Taiwan University Hospital

Anthony Tolcher, MD

Director, Clinical Research, START LLC, US

Dan Zhang, MD, MPH

CEO, Fountain Medical Development Ltd., China



                 (Photo: Dr. Tolcher is giving a presentation about START San Antonio)


For more information and the presentations' slides, please contact: